As cardiovascular (CV) clinical trials grow larger and more complex, drug developers face significant challenges regarding timelines and cost.
These pressures demand a global approach to trials and deep medical and operational expertise to prove the benefits of new therapies.
When you partner with PPD for CV research, you not only extend your global reach—you also gain the confidence of working with a partner who has been where you are—and has succeeded.
Gain Confidence Through PPD’s Experience
PPD has the experience, operational capacity and global resources required to effectively support protocol development and manage complex trial execution. Details
Working with PPD means working with a partner who has been where you are—and has succeeded.
In the past five years, PPD has conducted more than 100 CV studies with thousands of patients globally in programs ranging from single-site dose explorations to multi-national outcomes studies.
PPD has the experience, operational capacity and global resources required to effectively support protocol development and manage complex trial execution.
During the past five years, PPD has conducted:
100+ CV trials involving more than 76,000 patients and 7,600 sites
11 CV outcomes studies involving more than 83,000 patients and 8,100 sites
White Paper: Effective End Point Management in the Changing Research Landscape
Members of PPD’s CV team discuss how to successfully address end point management and provide insight into the best practices used by PPD’s pharmacovigilance group.
Read it now
PPD’s team of more than 5,000 cardiologists and 1,900 scientific and operational experts apply their collective therapeutic experience and insight to the planning and execution of CV studies.
The Partner of Choice in CV Research
Learn more about how PPD’s leading expertise, global resources and technology make us the partner of choice in CV research.
*.pdf files - these files require Adobe Reader pdf viewer